Category Archives: Diabetes and endocrinology

Hormone replacement therapy is safe and effective after all

November 14, 2017- Interviewed by Steven E. Greer, MD We interviewed JoAnn Manson, MD, DrPH about her JAMA paper that followed the cohorts in

Posted in - JAMA, Cardiology, Diabetes and endocrinology, FDA, Geriatrics, Harvard, Obstetrics and Gynecology, Oncology, Orthopedic surgery, Primary care medicine | Leave a comment

The bionic pancreas data

July 2, 2014- Interviewed by Steven E. Greer, MD The New England Journal of Medicine recently published the early clinical data on the “bionic pancreas”

Posted in - Medical Devices, - NEJM, Boston University, Diabetes and endocrinology | Leave a comment

Is Vitamin-D deficiency overdiagnosed?

November 8, 2016- Interviewed by Steven E. Greer, MD We interviewed JoAnn E. Manson, MD, DrPH, Chief, Division of Preventive Medicine,  Brigham

Posted in - NEJM, - Policy, CDC, Diabetes and endocrinology, FDA, Harvard, Primary care medicine | Leave a comment

Aerobic or Resistance Exercise, or Both, in Dieting Obese Older Adults

June 14, 2017- Interviewed by Steven E. Greer, MD We interviewed Dennis Villareal, MD, the author of the NEJM paper “Aerobic or Resistance

Posted in - NEJM, Bariatric surgery, Baylor, Diabetes and endocrinology, Geriatrics, Internal Medicine | Leave a comment

Vagal nerve stimulation for weight loss

January 22, 2015- Interviewed by Steven E. Greer, MD Erik Dutson, MD, bariatric surgeon from UCLA, discusses the newly FDA-approved weight loss device called

Posted in - Medical Devices, Bariatric surgery, Diabetes and endocrinology, Gastroenterology and liver, Primary care medicine, UCLA | Leave a comment

Tandem Diabetes

August 27, 2015- Interviewed by Steven E. Greer, MD

Posted in - Medical Devices, Diabetes and endocrinology | Leave a comment

How did a small academic lab succeed where big medical device companies failed?

July 5, 2014- Interviewed by Steven E. Greer, MD The New England Journal of Medicine recently published the early clinical data on the “bionic pancreas”

Posted in - Medical Devices, - NEJM, Boston University, Diabetes and endocrinology | Leave a comment

Overview of rHGH therapy

January 14, 2015- Interviewed by Steven E. Greer, MD We interviewed Dr. Shlomo Melmed, Director of the Clinical Research Institute and Dean of Faculty at

Posted in Cedars Sinai, Diabetes and endocrinology | Leave a comment

Using Afrezza inhaled insulin with a CGM

November 3, 2014- Interviewed by Steven E. Greer, MD Inhaled insulin will make a comeback when Mannkind’s drug, Afrezza, goes on sale in early 2015.

Posted in - Pharma, Diabetes and endocrinology, Primary care medicine, Univ Miami | Leave a comment

Hacking CGM’s to smartphones

October 31, 2014– Interviewed by Steven E. Greer, MD Type 1 diabetes patients using continuous glucose monitors have been creating their own software,

Posted in - Medical Devices, Diabetes and endocrinology | Leave a comment

Jay Skyler discusses the recent bionic pancreas data

June 22, 2014- By Steven E. Greer, MD This week, the mainstream press reported on the “bionic pancreas” data published in the NEJM

Posted in - Medical Devices, - NEJM, Diabetes and endocrinology | Leave a comment

The serious adverse events caused by topical testoserone

March 1, 2014

Posted in - Pharma, Dermatology, Diabetes and endocrinology, FDA | Leave a comment

Alex Rodriguez’s PED schedule

January 12, 2014- By Steven E. Greer, MD CBS’s “60 Minutes” interviewed the man, Anthony Bosch, claiming to have been the pseudo-doctor

Posted in - Opinion, - Pharma, Congress, Diabetes and endocrinology | Leave a comment

The clinical hurdles to prescribing CGM

October 31, 2014– Interviewed by Steven E. Greer, MD The portion of total Type 1 diabetes patients who use continuous glucose monitors (CGM)

Posted in - Medical Devices, CMS, Diabetes and endocrinology | Leave a comment

Interview with MannKind’s CEO, Al Mann, and CFO, Matt Pfeffer.

October 23,  2013- Interviewed by Steven E.  Greer, MD The Healthcare Channel interviewed the CEO of MannKind, Al Mann, and the CFO, Matt Pfeffer.

Posted in - Medical Devices, Diabetes and endocrinology, FDA | Leave a comment

Super rapid acting insulin and inhaled insulin

September 9, 2013- Interviewed by Steven E. Greer, MD Jay Skyler, MD, PhD, Deputy Director of the Diabetes Research Institute at The University

Posted in - Biotech, - Pharma, Diabetes and endocrinology, Univ Miami | Leave a comment

Book review of “Fat Chance” by Robert H. Lustig, MD

February 9, 2013- by Steven E. Greer, MD How did our ancient ancestors evolve from being pure meat

Posted in - Policy, - Reviews, books, devices, Diabetes and endocrinology, FDA, Pediatrics | Leave a comment

Book review of “Fat Chance” by Robert H. Lustig, MD

February 9, 2013- by Steven E. Greer, MD How did our ancient ancestors evolve from being pure meat eating carnivore hunters into grain fed farmers, and which diet is healthier? With nearly 7 Billion people on planet earth, how did … Continue reading

Posted in - Reviews, books, devices, Bariatric surgery, Diabetes and endocrinology, Pediatrics, UC San Francisco | Leave a comment

High fructose consumption and fatty liver disease

Manal F. Abdelmalek, MD, MPH, of the Duke Medical Center’s Division of Gastroenterology/Hepatology

Posted in Diabetes and endocrinology, Duke, FDA, Pediatrics | Leave a comment

Steven Cummings, MD: The denosumab FREEDOM trial

August 11, 2009- Dr. Steven Cummings, director of the San Francisco Coordinating Center and faculty of UCSF, and

Posted in - Biotech, - NEJM, - Pharma, Diabetes and endocrinology, Obstetrics and Gynecology, Orthopedic surgery, Primary care medicine, Radiology, Spine surgery, Sports medicine, UC San Francisco | Leave a comment